Document Detail

Outcome improvement of cellular cardiomyoplasty using triple therapy: Mesenchymal stem cell+erythropoietin+vascular endothelial growth factor.
MedLine Citation:
PMID:  23850947     Owner:  NLM     Status:  Publisher    
To improve cellular cardiomyoplasty efficacy after myocardial infarction (MI), we postulated that combining mesenchymal stem cells (MSCs) transplantation with anti-apoptotic and angiogenic effects of erythropoietin (EPO) and vascular endothelial growth factor (VEGF) may provide better prognosis in an infarcted heart 48 rats, underwent left anterior descending artery ligation, were divided into eight groups and treated as follows: Group 1: MSC+EPO+VEGF, Group 2: MSC+EPO, Group 3: MSC+VEGF, Group 4: MSC, Group 5: EPO+VEGF, Group 6: EPO, Group 7: VEGF and Group 8: Control. After MI induction, EPO and VEGF were injected subcutaneously at the dose of 3000U/kg and 3µg/kg respectively. MSCs were transplanted one week after MI. In the fourteenth and sixteenth days after infarction, EPO was injected again. Echocardiography demonstrated that all treatments improved left ventricular function significantly (before vs. after treatment) but in control group ejection fraction deteriorated over the 2-months period. Percent of ejection fraction recovery in all treatment groups were significantly greater than control (P<0.05). Compared with the control group, all treatments attenuated cell death in peri-infarct areas significantly, except groups 6 and 7. Vascular density of all treatment groups were more than control group but this superiority was statistically significant only in group1 (P<0.01). All of our treatments had beneficial effects to some extent but MSC transplantation combined with EPO and VEGF administration resulted in superior therapeutic outcome in enhancing cell survival and neovascularization.
Fatemeh Tavakoli; Seyed Nasser Ostad; Vahid Khori; Ali Mohammad Alizadeh; Anita Sadeghpour; Amir Darbandi Azar; Majid Haghjoo; Asghar Zare; Mohsen Nayebpour
Related Documents :
1267547 - Normalization of abnormal t waves in ischemia.
12607197 - Diminution of qrs complexes caused by anasarca after an acute myocardial infarction: a ...
7410997 - Increase in r-wave amplitude during transient epicardial injury (prinzmetal type).
7588897 - Comparison and combination of late potentials and spectral turbulence analysis to predi...
20549457 - Left ventricular lipoma with pseudoaneurysm-like appearance.
2419697 - Effect of verapamil on regional myocardial contraction during graded ischemia in the dog.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-7-9
Journal Detail:
Title:  European journal of pharmacology     Volume:  -     ISSN:  1879-0712     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-7-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier B.V. All rights reserved.
Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran-1417614411, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement ...
Next Document:  Evaluation of Luminex xTAG(R) Gastrointestinal Pathogen Analyte Specific Reagents for high-throughpu...